Peptide Therapy Cost: What to Expect in 2026

If you’ve been researching peptide therapy and hit a wall trying to figure out what it actually costs, you’re not alone. Pricing in this space is all over the map — and for good reason. The term “peptide therapy” covers everything from FDA-approved GLP-1 drugs that run over $1,000/month at retail to compounded BPC-157 vials that cost $60.

This guide breaks down real pricing across every major peptide category so you can budget accurately. We’ll also cover what drives costs up or down, and where people end up overpaying. If you’re curious about what kind of results these treatments deliver, check out our peptide therapy before and after guide for documented outcomes.

Key Takeaways

• Monthly costs range from $150 to $2,000+ depending on which peptide, whether it’s brand-name or compounded, and your clinic’s markup [1]
• GLP-1 peptides (semaglutide, tirzepatide) are the most expensive, running $300-$1,500/month depending on source and dosage
• Recovery and growth hormone peptides (BPC-157, CJC-1295) cost $150-$400/month through compounding pharmacies
• The biggest cost variable isn’t the peptide itself — it’s the clinic model (concierge vs. telehealth vs. DIY)

Table of Contents

1. Cost by Peptide Category
2. Weight Loss Peptide Costs
3. Recovery Peptide Costs
4. Growth Hormone Peptide Costs
5. Skin and Anti-Aging Peptide Costs
6. What Drives the Price Up
7. Brand-Name vs. Compounded Pricing
8. The Hidden Costs Most People Miss
9. Insurance Coverage
10. How to Reduce Your Costs
11. FAQ
12. Sources

Cost by Peptide Category

Here’s an honest snapshot of what people are paying in 2026 across the major peptide categories. These numbers come from clinic pricing pages, pharmacy quotes, and patient reports — not marketing copy.

Peptide Category	Monthly Cost Range	Typical Duration
GLP-1s (semaglutide, tirzepatide)	$200–$1,500	6-12+ months
Recovery (BPC-157, TB-500)	$150–$400	4-12 weeks
Growth Hormone Secretagogues (CJC-1295, Ipamorelin)	$200–$500	3-6 months
Skin/Anti-Aging (GHK-Cu)	$100–$300	8-12 weeks
Sexual Health (PT-141)	$100–$250	As needed

These are peptide-only costs. They don’t include consultations, lab work, or supplies — all of which add up. More on that below.

Weight Loss Peptide Costs

Weight loss peptides are where the biggest price swings happen. The same active ingredient can cost 10x more depending on where you get it.

Semaglutide is the heavyweight here. Brand-name Wegovy lists at roughly $1,350/month without insurance [2]. Compounded semaglutide from a 503B pharmacy runs $150–$350/month, though the FDA’s evolving stance on compounding has created supply uncertainty in 2026 [3].

Tirzepatide (Mounjaro/Zepbound) follows a similar pattern — around $1,000-$1,100/month retail, $200-$400 compounded. For a detailed comparison of these two, see our semaglutide vs. tirzepatide breakdown.

The STEP UP trial showed semaglutide 7.2 mg produced an average 20.7% body weight loss, with 33% of participants losing more than 25% [4]. At any price point, those are significant results for people with obesity — but the cost-per-pound-lost math favors compounded versions heavily.

If you’re exploring this route, our peptides for weight loss guide covers which compounds have the strongest evidence.

Recovery Peptide Costs

Recovery peptides like BPC-157 and TB-500 sit at the more affordable end of the spectrum, partly because treatment courses are shorter.

BPC-157 typically runs $150–$300 for a full 4-8 week course. A standard vial (5mg) costs $60-$100 from compounding pharmacies. At common dosing protocols (250-500mcg/day), one vial lasts roughly 10-20 days [5].

TB-500 costs slightly more — $200–$400 for an 8-12 week course. Many people stack BPC-157 and TB-500 together (the so-called Wolverine stack), which doubles the peptide cost but not the supply or consultation fees.

What you’re buying: A 2025 systematic review found BPC-157 improved outcomes in muscle, tendon, ligament, and bone injury models. In one small human study, 7 of 12 patients with chronic knee pain reported relief lasting over six months from a single injection [6]. That’s promising, but the evidence base is still mostly animal data.

The regulatory picture for BPC-157 shifted in 2024 when the FDA placed it on the “demonstrable difficulties” list, restricting compounding. Some clinics have pivoted to alternative formulations or switched to oral BPC-157 capsules, which can be cheaper ($80-$150/month) but have different absorption profiles.

Growth Hormone Peptide Costs

Growth hormone secretagogues like CJC-1295 and Ipamorelin are mid-range on price and typically used for 3-6 month cycles.

CJC-1295/Ipamorelin combo runs $250–$500/month from most clinics. The peptides themselves cost $100-$200 through compounding pharmacies — clinics add their margin on top for the prescription, monitoring, and protocol design [7].

Sermorelin is slightly cheaper, typically $200-$400/month. It has a longer safety track record since it was FDA-approved (later withdrawn for commercial reasons, not safety) [8].

Tesamorelin is the outlier — it’s fully FDA-approved for HIV-associated lipodystrophy and costs $800-$1,500/month, mostly covered by insurance for that specific indication.

These peptides require consistent use over months before results show up. Budget for at least a 3-month commitment before deciding if they’re working.

Skin and Anti-Aging Peptide Costs

Skin-focused peptides are among the most affordable options.

GHK-Cu costs $100-$250/month depending on form. Topical GHK-Cu creams run $40-$80/month. Injectable GHK-Cu is pricier at $150-$250 for an 8-12 week course. A 2018 study showed topical GHK-Cu improved collagen production in 70% of women treated over 12 weeks — outperforming both vitamin C cream (50%) and retinoic acid (40%) [9].

Matrixyl and other cosmetic peptides are available over the counter in serums for $20-$60/month. These aren’t prescription peptides but they do have clinical data supporting modest improvements in wrinkle depth.

What Drives the Price Up

Five factors explain most of the price variation you’ll see:

1. Clinic model. Concierge clinics with in-person visits charge $500-$2,000/month for the same peptides that telehealth clinics offer for $200-$500. You’re paying for the experience and the doctor’s time, not a better product.

2. Lab work. Most responsible clinics require baseline labs and periodic monitoring. Expect $200-$500 for initial panels and $100-$300 for follow-ups every 2-3 months.

3. The peptide itself. GLP-1s cost more than BPC-157, which costs more than GHK-Cu. This reflects manufacturing complexity, patent status, and demand.

4. Dosing protocol. Higher doses cost more. Semaglutide at 2.4mg/week costs roughly 3x what the 0.5mg starting dose costs.

5. Supply costs. Syringes, bacteriostatic water, alcohol swabs, and sharps containers add $20-$50/month. Learning how to reconstitute peptides yourself saves money compared to clinics that charge for pre-mixed vials.

Brand-Name vs. Compounded Pricing

This is the single biggest cost lever for most patients.

Brand-name peptides (Wegovy, Mounjaro, Ozempic) go through full FDA approval, cost billions to develop, and are priced accordingly. Compounded versions use the same active ingredient, prepared by licensed pharmacies, at a fraction of the cost.

The trade-off is straightforward: brand-name products have rigorous quality control, batch testing, and established safety profiles. Compounded products vary in quality depending on the pharmacy. Some 503B compounding pharmacies maintain excellent standards. Others have had contamination issues [10].

In 2026, the regulatory environment is shifting. The FDA has been tightening compounding rules for GLP-1 peptides as brand-name supply stabilizes. This could push compounded prices up or reduce availability altogether.

Practical advice: If cost is a deciding factor, ask your clinic which 503B pharmacy they use, whether the pharmacy is FDA-registered, and whether they provide certificates of analysis for each batch.

The Hidden Costs Most People Miss

The peptide vial is rarely the full picture. Here’s what catches people off guard:

• Initial consultation: $150-$400 (some clinics fold this into the first month)
• Lab work: $200-$500 baseline, $100-$300 follow-ups
• Supplies: $20-$50/month for syringes, swabs, bacteriostatic water
• Shipping: $15-$30 per shipment (cold chain shipping costs more)
• Follow-up visits: $75-$200 every 4-8 weeks
• Medication adjustments: Protocol changes may require new vials before the old ones are used up

A realistic all-in budget for your first month is typically 30-50% higher than the quoted peptide price.

Insurance Coverage

Here’s the blunt version: insurance covers very few peptide therapies.

Covered (with prior authorization and specific diagnoses):

• Semaglutide (Wegovy) for obesity with BMI ≥30 or ≥27 with comorbidities
• Tirzepatide (Zepbound) — similar criteria
• Tesamorelin for HIV-associated lipodystrophy
• Some growth hormone therapies for diagnosed GH deficiency

Not covered:

• Compounded peptides of any kind
• BPC-157, TB-500, CJC-1295, Ipamorelin
• GHK-Cu
• Any off-label peptide use

Even for covered peptides, prior authorization is a hassle. Many patients report 2-6 weeks of back-and-forth with insurers before approval [11]. Some clinics offer cash-pay programs that are faster, though you lose the insurance discount.

HSA and FSA accounts can typically be used for prescribed peptide therapies, including compounded ones, as long as you have a valid prescription.

How to Reduce Your Costs

Some practical strategies that work:

Use telehealth clinics. Online peptide clinics charge 30-50% less than brick-and-mortar practices for the same compounds. You lose the in-person relationship but gain significant savings.

Buy multi-month supplies. Many pharmacies and clinics offer 10-20% discounts on 3-month orders.

Learn to self-administer. Subcutaneous injections are straightforward to do at home. Paying a clinic for injection visits adds $50-$100 per shot that most people don’t need to spend.

Compare pharmacy prices. Compounding pharmacy prices vary significantly. Get quotes from 2-3 pharmacies before committing.

Consider oral formulations. Oral BPC-157 and oral semaglutide (Rybelsus) are available at different price points than injectable versions. Bioavailability differs, but for some people the trade-off makes sense.

Side Effects and Safety

Cost shouldn’t be the only factor. Cheaper isn’t better if you’re getting an under-dosed or contaminated product.

The most common side effects across peptide categories include injection site reactions (redness, swelling), nausea (especially with GLP-1s), headaches, and fatigue during the first 1-2 weeks [12].

GLP-1 peptides carry additional risks including pancreatitis (rare but serious), gallbladder issues, and gastrointestinal side effects in 30-50% of users [13].

For recovery peptides like BPC-157, animal studies have shown no harmful effects, but there is practically no published human safety data beyond the single small trial mentioned above [6]. That’s an important gap.

Bottom line: Work with a licensed provider who monitors your progress. The cost of a doctor who knows what they’re doing is the best money you’ll spend in this process.

FAQ

How much does peptide therapy cost per month?▼

Most people spend $200-$600/month depending on which peptide they’re using. GLP-1 weight loss peptides run $200-$1,500/month. Recovery peptides like BPC-157 cost $150-$400 for a full treatment course of 4-8 weeks.

Is peptide therapy covered by insurance?▼

Only FDA-approved peptides prescribed for approved indications. Semaglutide (Wegovy) and tirzepatide (Zepbound) can be covered for obesity. Compounded peptides and off-label use are not covered.

Why is peptide therapy so expensive?▼

Three factors: the peptide manufacturing process requires specialized equipment and quality control, clinic markups cover physician time and monitoring, and brand-name products carry pharmaceutical pricing. Compounded versions reduce the peptide cost, but clinic fees remain.

What is the cheapest peptide therapy?▼

Topical GHK-Cu for skin improvement runs $40-$80/month. For injectable peptides, BPC-157 is among the most affordable at $150-$300 for a full treatment course. Telehealth clinics and self-administration further reduce costs.

Are compounded peptides safe?▼

Compounded peptides from FDA-registered 503B pharmacies with certificates of analysis are generally considered safe by practitioners in this space. However, they lack the batch-by-batch FDA oversight that brand-name products receive. Quality varies significantly between pharmacies. Ask for third-party testing results.

Sources

1. Lau JL, Dunn MK. “Therapeutic peptides: Historical perspectives, current development trends, and future directions.” Bioorganic & Medicinal Chemistry. 2018;26(10):2700-2707. doi:10.1016/j.bmc.2017.06.052
2. Novo Nordisk. Wegovy (semaglutide) prescribing information and wholesale acquisition cost. 2024.
3. FDA. “Compounding and the FDA: Questions and Answers.” Updated 2025. fda.gov/drugs/human-drug-compounding
4. Novo Nordisk. “STEP UP trial: Semaglutide 7.2mg achieves 20.7% weight loss.” Press release, February 2025.
5. Sikiric P, et al. “Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease.” Current Pharmaceutical Design. 2011;17(16):1612-1632. doi:10.2174/138161211796197115
6. Vasireddi N, et al. “Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.” Orthopaedic Journal of Sports Medicine. 2025. doi:10.1177/15563316251355551
7. Teichman SL, et al. “Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295.” J Clin Endocrinol Metab. 2006;91(3):799-805. doi:10.1210/jc.2005-1536
8. Walker RF. “Sermorelin: A better approach to management of adult-onset growth hormone insufficiency?” Clinical Interventions in Aging. 2006;1(4):307-308.
9. Pickart L, Vasquez-Soltero JM, Margolina A. “Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.” Int J Mol Sci. 2015;16(9):20948-20969. doi:10.3390/ijms160920948
10. FDA. “FDA alerts consumers about potentially unsafe compounded semaglutide products.” Safety alert, 2024.
11. KFF Health Tracking Poll. “Barriers to accessing GLP-1 medications.” 2024.
12. Wilding JPH, et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” N Engl J Med. 2021;384:989-1002. doi:10.1056/NEJMoa2032183
13. Jastreboff AM, et al. “Tirzepatide Once Weekly for the Treatment of Obesity.” N Engl J Med. 2022;387:205-216. doi:10.1056/NEJMoa2206038